ASCO’s guideline adaptation similarly advises that there is insufficient evidence to routinely prescribe medications for CRF, apart from treating underlying conditions (like antidepressants for depression, or erythropoietin for chemotherapy-induced anaemia). This evidence concerns the gene EPO and anemia (phenotype).